Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng Gee Lim

Showing results (161-170 of 241) with videos related to

Pageof 25
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2007
MARS: a futile tool in centres without active liver transplant supportChun-Tao Wai, Seng-Gee Lim, Myot-Oo Aung, et al.
Gastroenterology|November 10, 2015
Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and MilkGuan-Huei Lee, Boon-Huan Tan, Esmeralda Chi-Yuan Teo, et al.
BMC Genomics|October 29, 2017
Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic historyYuan O Zhu, Pauline P K Aw, Paola Florez de Sessions, et al.
Hepatology International|January 11, 2020
Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficaciousMark D Muthiah, En Ying Tan, Sin Hui Melissa Chua, et al.
Gastroenterology|November 8, 2006
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 yearsStephanos J Hadziyannis, Nicolaos C Tassopoulos, E Jenny Heathcote, et al.
The Lancet. Gastroenterology & Hepatology|November 6, 2018
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trialTarik Asselah, Samuel S Lee, Betty B Yao, et al.
Viruses|May 27, 2026
Identification of Cyclin L1 as a Host Factor Regulating Hepatitis B Virus ReplicationCollins Oduor Owino, Balakrishnan Chakrapani Narmada, Gian Yi Lin, et al.
Hepatology International|July 24, 2015
APASL consensus statements and management algorithms for hepatitis C virus infectionMasao Omata, Tatsuo Kanda, Ming-Lung Yu, et al.
Journal of Virology|February 26, 2005
Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agentsChoong-Tat Keng, Aihua Zhang, Shuo Shen, et al.
Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
Pageof 25

Showing results (161-170 of 241) with videos related to

Sort By:
Pageof 25
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2007
MARS: a futile tool in centres without active liver transplant supportChun-Tao Wai, Seng-Gee Lim, Myot-Oo Aung, et al.
Gastroenterology|November 10, 2015
Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and MilkGuan-Huei Lee, Boon-Huan Tan, Esmeralda Chi-Yuan Teo, et al.
BMC Genomics|October 29, 2017
Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic historyYuan O Zhu, Pauline P K Aw, Paola Florez de Sessions, et al.
Hepatology International|January 11, 2020
Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficaciousMark D Muthiah, En Ying Tan, Sin Hui Melissa Chua, et al.
Gastroenterology|November 8, 2006
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 yearsStephanos J Hadziyannis, Nicolaos C Tassopoulos, E Jenny Heathcote, et al.
The Lancet. Gastroenterology & Hepatology|November 6, 2018
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trialTarik Asselah, Samuel S Lee, Betty B Yao, et al.
Viruses|May 27, 2026
Identification of Cyclin L1 as a Host Factor Regulating Hepatitis B Virus ReplicationCollins Oduor Owino, Balakrishnan Chakrapani Narmada, Gian Yi Lin, et al.
Hepatology International|July 24, 2015
APASL consensus statements and management algorithms for hepatitis C virus infectionMasao Omata, Tatsuo Kanda, Ming-Lung Yu, et al.
Journal of Virology|February 26, 2005
Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agentsChoong-Tat Keng, Aihua Zhang, Shuo Shen, et al.
Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
Pageof 25